Successful management of Blastomyces dermatitidis meningitis

Infections in Medicine

Volumn 23, Issue 1, 2006, Pages 39-41

  Lentnek, Arnold L ^a,b   Lentnek, Ian A ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Lenox Hill Hospital ^*

^c LENOX HILL HOSPITAL   (United States)

Author keywords

Amphotericin B; Blastomycosis; Meningitis; Voriconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CELECOXIB; DIAZEPAM; ESOMEPRAZOLE; MIRTAZAPINE; PROMETHAZINE; VORICONAZOLE;

ADULT; ARTICLE; ATAXIA; BALANCE IMPAIRMENT; BLASTOMYCES DERMATITIDIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONFUSION; DISORIENTATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FATIGUE; FOLLOW UP; HEADACHE; HEARING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; LEUKOCYTOSIS; LUMBAR PUNCTURE; MALAISE; MALE; MYCOTIC MENINGITIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OTOTOXICITY; PHOTOPHOBIA; SLURRED SPEECH; TINNITUS; UNILATERAL HEARING LOSS; VERTIGO; VOMITING;

EID: 33645742134     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kuzo RS, Goodman LR. Blastomycosis. Semin Roentgenol. 1996;31:45-51.
2. Benzel EC, King JW, Mirfakhraee M, et al. Blastomycotic meningitis. Surg Neurol. 1986;26:192-196.
3. Sekhon AS, Jackson FL, Jacobs HJ. Blastomycosis: report of the first case from Alberta, Canada. Mycopathologia. 1982;79:65-69.
4. Kravitz GR, Davies SF, Eckman MR. Sarosi GA. Chronic blastomycotic meningitis. Am J Med. 1981;71:501-505.
5. Gonyea EF. The spectrum of primary blastomycotic meningitis: a review of central nervous system blastomycosis. Ann Neurol. 1978;3:26-39.
6. Sekhon AS, Kaufman L, Kobayashi GS, et al. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol. 1995;33:123-125.
7. Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore). 1993;72:311-325.
8. Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev. 1995;8:146-159.
9. McGinnis MR, Pasarell L, Sutton DA, et al. In vitro evaluation of voriconazole against some clinically important fungi Antimicrob Agents Chemother. 1997;41:1832-1834.
10. Sugar AM, Liu X-P. Efficacy of voriconazole in treatment of marine pulmonary blastomycosis. Antimicrob Agents Chemother. 2001;45:601-604.
11. Nesky MA, McDougal EC, Peacock JE Jr. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis. 2000;31:673-677.
12. Hoepelman AIM, Hodges MR, Lutsar I. Cerebral aspergillosis and scedosporiosis: voriconazole, a new treatment option for children with life threatening cerebral fungal infection. 18th European Society for Pediatric Diseases; May 2000; Noordwijk, the Netherlands. Poster 72.
13. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol. 1997;97:663-665.
14. Poza G, Montoya J, Redondo C, et al. Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin Infect Dis. 2000;30:981-982.
15. Cortez KJ, Walsh TJ, Bennett JE. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis. 2003;36:1619-1622.